Showing results 1 to 20 of 31
next >
| Issue Date | Title | Author(s) |
| Mar-2020 | Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy | Fan, Rong; Zhou, Bin; Xu, Min; Tan, Deming; Niu, Junqi; Wang, Hao; Ren, Hong; Chen, Xinyue; Wang, Maorong; Ning, Qin; Shi, Guangfeng; Sheng, Jifang; Tang, Hong; Bai, Xuefan; Liu, Shi; Lu, Fengmin; Peng, Jie; Sun, Jian; Xie, Qing; Hou, Jinlin; Wan, Mobin; Chen, Shijun; Yu, Yanyan; Ma, Hong; Cheng, Jun; Zhang, Hongfei; Liu, Huimin; Gao, Zhiliang; Sun Yat-Sen; Dou, Xiaoguang |
| 2018 | Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B | Yu, Rui; Tan, Deming; Ning, Qin; Niu, Junqi; Bai, Xuefan; Chen, Shijun; Cheng, Jun; Yu, Yanyan; Wang, Hao; Xu, Min; Shi, Guangfeng; Wan, Mobin; Chen, Xinyue; Tang, Hong; Sheng, Jifang; Dou, Xiaoguang; Shi, Junping; Ren, Hong; Wang, Maorong; Zhang, Hongfei; Gao, Zhiliang; Chen, Chengwei; Ma, Hong; Jia, Jidong; Hou, Jinlin; Xie, Qing; Sun, Jian |
| Jun-2021 | Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy | Fan, Rong; Niu, Junqi; Ma, Hong; Xie, Qing; Cheng, Jun; Rao, Huiying; Dou, Xiaoguang; Xie, Jianping; Zhao, Wei; Peng, Jie; Gao, Zhiliang; Gao, Hongbo; Chen, Xinyue; Chen, Jinjun; Li, Qiang; Tang, Hong; Zhang, Zhengang; Ren, Hong; Cheng, Mingliang; Liang, Xieer; Zhu, Chaonan; Wei, Lai; Jia, Jidong; Sun, Jian; Hou, Jinlin |
| 2013 | Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir | Sun, Jian; Yuan, Quan; Xie, Qing; Fan, Rong; Tan, Deming; Ning, Qin; Niu, Junqi; Bai, Xuefan; Song, Liuwei; Chen, Shijun; Cheng, Jun; Yu, Yanyan; Wang, Hao; Xu, Min; Shi, Guangfeng; Wan, Mobin; Chen, Xin-Yue; Tang, Hong; Sheng, Jifang; Dou, Xiaoguang; Shi, Junping; Ren, Hong; Wang Maorong; Zhang, Hongfei; Gao, Zhiliang; Chen, Chengwei; Ma, Hong; Jia, Jidong; Xia, Ningshao; Hou, Jinlin |
| 2019 | Comparison of the efficacy of sofosbuvir plus ribavirin in Chinese patients with genotype 3a or 3b HCV infectionn | Huang, Rui; Rao, Huiying; Xie, Qing; Gao, Zhiliang; Li, Wu; Jiang, Deyuan; Mo, Hongmei; Massetto, Benedetta; Stamm, Luisa M.; Brainard, Diana M.; Wei, Lai |
| 2014 | Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection | Rao, Huiying; Wei, Lai; Carlos Lopez-Talavera, Juan; Shang, Jia; Chen, Hong; Li, Jun; Xie, Qing; Gao, Zhiliang; Wang, Lei; Wei, Jia; Jiang, Jianning; Sun, Yongtao; Yang, Ruifeng; Li, Hong; Zhang, Haiying; Gong, Zuojiong; Zhang, Lunli; Zhao, Longfeng; Dou, Xiaoguang; Niu, Junqi; You, Hong; Chen, Zhi; Ning, Qin; Gong, Guozhong; Wu, Shuhuan; Ji, Wei; Mao, Qing; Tang, Hong; Li, Shuchen; Wei, Shaofeng; Sun, Jian; Jiang, Jiaji; Lu, Lungen; Jia, Jidong; Zhuang, Hui |
| Nov-2023 | Editorial: HBsAg seroclearance after pegylated interferon treatment-The beginning of the end. Authors' reply | Gao, Na; Guan, Guiwen; Zhao, Qiyi; Gao, Zhiliang |
| 2019 | Efficacy and Safety of 12-week Interferon-based Danoprevir Regimen in Patients with Genotype 1 Chronic Hepatitis C | Wei, Lai; Shang, Jia; Ma, Yuanji; Xu, Xiaoyuan; Huang, Yan; Guan, Yujuan; Duan, Zhongping; Zhang, Wenhong; Gao, Zhiliang; Zhang, Mingxiang; Li, Jun; Jia, Jidong; Yang, Yongfeng; Wen, Xiaofeng; Wang, Maorong; Jia, Zhansheng; Ning, Bo; Chen, Yongping; Qi, Yue; Du, Jie; Jiang, Jianning; Tong, Lixin; Xie, Yao; Wu, Jinzi J. |
| Mar-2025 | Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trial | Zhang, Mingyuan; Gao, Yanhang; Kong, Fei; Gao, Haibing; Yi, Yongxiang; Wu, Chao; Xin, Yongning; Zheng, Sujun; Lu, Jiajie; Han, Tao; Zhao, Yingren; Hu, Peng; Mao, Xiaorong; Xie, Qing; Zhang, Jie; Hou, Jinlin; Gao, Zhiliang; Lian, Jianqi; Chen, Liang; Shang, Jia; Xie, Wen; Mu, Mao; Jin, Zhenjing; Wang, Maorong; Lin, Shide; Rao, Huiying; Yang, Dongliang; Gong, Huanyu; Luo, Lin; Chen, Yunfu; Zhuang, Yulei; Zhang, Yingjun; Gish, Robert G.; Tan, Youwen; Zhang, Jiming; Niu, Junqi |
| Oct-2021 | FUNCTIONAL CURE BASED ON PEGYLATED INTERFERON alpha IN LONG-TERM NUCLEOSIDE ANALOG SUPPRESSED HBEAG NEGATIVE CHRONIC HEPATITIS B: A MULTICENTER REAL-WORLD STUDY (EVEREST PROJECT IN CHINA), A SEQUENTIAL REPORT - THE PREDICTORS FOR HBsAg LOSS | Wu, Zeqian; Xie, Dongying; Fu, Lei; Zhang, Wenhua; Wei, Jia; Shang, Jia; Li, Guojun; Guo, Ying; Yang, Jiahong; Guan, Yujuan; Li, Jiabin; Chang, Jiabao; Huang, Guangyu; Peng, Yanzhong; Lin, Minghua; Zeng, Yilan; Li, Jia; Jiang, Jiaji; Jiang, Yongfang; Gu, Ye; Geng, Jiawei; Gao, Zhiliang |
| Jul-2022 | Functional cure based on pegylated interferon alpha therapy in nucleoside analog-suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest Project in China)-3.5 years data update | Xie, Chan; Xie, Dongying; Fu, Lei; Zhang, Wen-hua; Wei, Jia; Li, Guojun; Yang, Jiahong; Chen, Xinyue; Li, Jia-bin; Shang, Jia; Guan, Yu-juan; Jiang, Yongfang; Guo, Ying; Zeng, Yi-lan; Chang, Jiabao; Peng, Yanzhong; Lin, Minghua; Huang, Guangyu; Li, Jia; Gu, Shengwang; Geng, Jia-wei; Gao, Zhiliang |
| 2016 | HBsAg and HBeAg in the prediction of a clinical response to peginterferon alpha-2b therapy in Chinese HBeAg-positive patients | Yang, Song; Xing, Huichun; Wang, Yuming; Hou, Jinlin; Luo, Duande; Xie, Qing; Ning, Qin; Ren, Hong; Ding, Huiguo; Sheng, Jifang; Wei, Lai; Chen, Shijun; Fan, Xiaoling; Huang, Wenxiang; Pan, Chen; Gao, Zhiliang; Zhang, Jiming; Zhou, Boping; Chen, Guofeng; Wan, Mobin; Tang, Hong; Wang, Guiqiang; Yang, Yuxiu; Xu, Dongping; Dong, Peiling; Wang, Qixin; Wang, Jue; Bognar, Fernando A.; Xu, Daozhen; Cheng, Jun |
| 2018 | Hepatitis C Virus Genotype 3, Particularly 3b, Is Associated with an Increased Risk of Liver Disease Progression in China National Cohort with Multiple Genotypes. | Wu, Nan; Rao, Huiying; Yang, Ruifeng; Sun, Yongtao; Fei, Ran; Gao, Yinghui; Jin, Qian; Yang, Weibo; Niu, Junqi; Gao, Zhiliang; Wei, Lai |
| 2018 | Hepatitis C Virus Genotype 3, Particularly 3b, Is Associated with an Increased Risk of Liver Disease Progression in China National Cohort with Multiple Genotypes. | Wu, Nan; Rao, Huiying; Yang, Ruifeng; Sun, Yongtao; Fei, Ran; Gao, Yinghui; Jin, Qian; Yang, Weibo; Niu, Junqi; Gao, Zhiliang; Wei, Lai |
| Jan-2024 | Higher TP53BP2 expression is associated with HBsAg loss in peginterferon-α-treated patients with chronic hepatitis B | Guan, Guiwen; Zhang, Ting; Ning, Jing; Tao, Changyu; Gao, Na; Zeng, Zhenzhen; Guo, Huili; Chen, Chia-Chen; Yang, Jing; Zhang, Jing; Gu, Weilin; Yang, Ence; Liu, Ren; Guo, Xiaosen; Ren, Shan; Wang, Lin; Wei, Guochao; Zheng, Sujun; Gao, Zhiliang; Chen, Xinyue; Lu, Fengmin; Chen, Xiangmei |
| 29-Aug-2023 | Integrated HBV DNA and cccDNA maintain transcriptional activity in intrahepatic HBsAg-positive patients with functional cure following PEG-IFN-based therapy | Gao, Na; Guan, Guiwen; Xu, Ganlin; Wu, Haishi; Xie, Chan; Mo, Zhishuo; Deng, Hong; Xiao, Shuying; Deng, Zhicong; Peng, Liang; Lu, Fengmin; Zhao, Qiyi; Gao, Zhiliang |
| 2019 | Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results | Liang, Xieer; Gao, Zhiliang; Xie, Qing; Zhang, Jiming; Sheng, Jifang; Cheng, Jun; Chen, Chengwei; Mao, Qing; Zhao, Wei; Ren, Hong; Tan, Deming; Niu, Junqi; Chen, Shijun; Pan, Chen; Tang, Hong; Wang, Hao; Mao, Yimin; Jia, Jidong; Ning, Qin; Xu, Min; Wu, Shanming; Li, Jun; Zhang, Xinxin; Zhang, Wenyan; Xiong, Cui; Hou, Jinlin |
| 2016 | A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis | Ma, Hong; Zeng, Minde; Han, Ying; Yan, Huiping; Tang, Hong; Sheng, Jifang; Hu, Heping; Cheng, Liufang; Xie, Qing; Zhu, Youfu; Chen, Guofeng; Gao, Zhiliang; Xie, Wen; Wang, Jiyao; Wu, Shanming; Wang, Guiqiang; Miao, Xiaohui; Fu, Xiaoqing; Duan, Liping; Xu, Jie; Wei, Lai; Shi, Guangfeng; Chen, Chengwei; Chen, Minhu; Ning, Qin; Yao, Chen; Jia, Jidong |
| Feb-2020 | Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries | Hou, Jin-Lin; Zhao, Wei; Lee, Changhyeong; Hann, Hie-Won; Peng, Cheng-Yuan; Tanwandee, Tawesak; Morozov, Viacheslav; Klinker, Hartwig; Sollano, Jose D.; Streinu-Cercel, Adrian; Cheinquer, Hugo; Xie, Qing; Wang, Yu-Ming; Wei, Lai; Jia, Ji-Dong; Gong, Guozhong; Han, Kwang-Hyub; Cao, Wukui; Cheng, Mingliang; Tang, Xiaoping; Tan, Deming; Ren, Hong; Duan, Zhongping; Tang, Hong; Gao, Zhiliang; Chen, Shijun; Lin, Shumei; Sheng, Jifang; Chen, Chengwei; Shang, Jia; Han, Tao; Ji, Yanyan; Niu, Junqi; Sun, Jian; Chen, Yongpeng; Cooney, Elizabeth L.; Lim, Seng-Gee |
| 2014 | Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: A randomized trial | Cheng, Jun; Wang, Yuming; Hou, Jinlin; Luo, Duande; Xie, Qing; Ning, Qin; Ren, Hong; Ding, Huiguo; Sheng, Jifang; Wei, Lai; Chen, Shijun; Fan, Xiaoling; Huang, Wenxiang; Pan, Chen; Gao, Zhiliang; Zhang, Jiming; Zhou, Boping; Chen, Guofeng; Wan, Mobin; Tang, Hong; Wang, Guiqiang; Yang, Yuxiu; Mohamed, Rosmawati; Guan, Richard; Lee, Tzong-Hsi; Chang, Wen-Hsiung; Huang Zhenfei; Ye, Zhang; Xu, Daozhen |
